MSCohi-O Lenses
Phase 1Small molecule
MSCohi-O Lenses is one of 2 small molecule programs targeting Sjögren's Syndrome. It is currently in Phase 1.
1
Indications
1
Total Trials
1
Active Trials
1
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
3 competitors in Sjögren's Syndrome
#DrugCompanyPhaseTrials
1Dazodalibep
AmgenPhase 3
MSCohi-O Lenses
GGuangdong ProCapZoom Biosciences Co., Ltd.
Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for MSCohi-O Lenses. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details